Pegfilgrastim biosimilar(Nora Pharma)

N/A

Report date: 2024/06/21 09:39:50

Base Information

Drug NamePegfilgrastim biosimilar(Nora Pharma)
Drug Alias Namea pegylated form of filgrastimNIOPEG
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsFebrile Neutropenia
Global Approved IndicationsFebrile Neutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2024/04/19
Country/TerritoryCanada
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNora Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesNora Pharma Inc
Inactive CompaniesN/A
Active IndicationsFebrile Neutropenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A